Genitourinary Radiology: Page 50

SNM: New therapy extends life for prostate cancer patients
By AuntMinnie.com staff writers
Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.
June 10, 2012
Accuray touts CyberKnife prostate SBRT study
By AuntMinnie.com staff writers
Radiation oncology firm Accuray is touting the results of a study that concluded that use of the company's CyberKnife system for prostate stereotactic body radiation therapy (SBRT) can provide positive long-term outcomes for intermediate-risk prostate cancer patients.
June 6, 2012
Beta-carotene safe for prostate cancer patients
By AuntMinnie.com staff writers
The antioxidant supplement beta-carotene is safe to use during radiation therapy treatments for prostate cancer, according to a study published in the May issue of the International Journal of Radiation Oncology, Biology, Physics.
May 31, 2012
SBRT instead of IMRT could reduce cost of prostate treatment
By Cynthia E. Keen
When a patient with organ-confined prostate cancer needs radiation therapy, replacing intensity-modulated radiation therapy (IMRT) with stereotactic body radiation therapy (SBRT) may be more cost-effective, according to an article published in the May issue of the Journal of Oncology Practice.
May 30, 2012
Moments in Radiology History: Part 5 -- Bullets and bones
By Otha Linton
"Bullets, bones, and kidney stones" was a phrase that sprung up in the earliest months of the medical use of x-rays. Just as Wilhelm Conrad Röntgen had noticed that x-rays showed bones minus normal flesh, young surgeons found that the images could show them where surgery could correct problems.
May 28, 2012
2012 03 21 09 34 31 312 Stamp 70x70 V2
ASTRO criticizes USPSTF stand on prostate screening
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has expressed its disappointment with the U.S. Preventive Services Task Force's (USPSTF) final recommendations against the use of prostate-specific antigen (PSA) screening for prostate cancer, and it cautioned against a blanket no-testing policy.
May 24, 2012
Studies support C-11 choline PET/CT for prostate cancer
By Wayne Forrest
PET/CT with a carbon-11 (C-11) choline radiotracer is effective for evaluating prostate cancer, and in many cases it is better than conventional imaging for detecting the disease, according to three papers presented this week at the American Urological Association annual meeting in Atlanta.
May 22, 2012
2012 05 23 08 54 56 520 Choline Pet Ct Karnes Thumb
ProUroCare gets FDA nod for ProUroScan system
By AuntMinnie.com staff writers
Prostate imaging developer ProUroCare Medical has received 510(k) clearance from the U.S. Food and Drug Administration for its ProUroScan prostate mechanical imaging system.
May 1, 2012
'One-size-fits-all' imaging cuts do more harm than good
By Kate Madden Yee
Attacking imaging overutilization through blanket reductions in reimbursement could have unintended consequences, according to a new study published in this month's Health Affairs. Such cuts could backfire by also reducing imaging for patients who need it.
April 19, 2012
Chemo with RT best for muscle-invasive bladder cancer
By Cynthia E. Keen
The combined treatment of chemotherapy and radiation therapy (RT) is more effective than radiation therapy alone for patients with muscle-invasive bladder cancer who don't have a cystectomy, according to a study to be published in the April 19 issue of the New England Journal of Medicine.
April 17, 2012
IMRT seems most effective radiation therapy for prostate cancer
By Cynthia E. Keen
The use of intensity-modulated radiation therapy (IMRT) for prostate cancer caused fewer toxicities and less cancer recurrence than conformal radiotherapy and proton therapy treatments, according to a study published in the April 18 issue of the Journal of the American Medical Association.
April 16, 2012
2012 04 20 11 08 21 212 Chen Imrt Prostate 450
USHIFU touts Lancet study results
By AuntMinnie.com staff writers
High-intensity focused ultrasound (HIFU) developer USHIFU is touting study results published online in Lancet Oncology. The results suggest that using HIFU to deliver focal treatment for prostate cancer could provide an alternative to traditional treatment with significantly fewer side effects, according to the company.
April 16, 2012
Previous Page
Page 50 of 93
Next Page